Papers using
Indo
antibodies
Papers on
Indo
Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion.Van den Eynde et al., Heidelberg, Germany. In Cancer Res, Dec 2012
It has been proposed that the essential amino acid tryptophan is catabolized in the tumor tissue by the rate-limiting enzyme indoleamine-2,3-dioxygenase (IDO) expressed in tumor cells or antigen-presenting cells.
Jack of all trades: thymosin α1 and its pleiotropy.Garaci et al., Perugia, Italy. In Ann N Y Acad Sci, Oct 2012
Additionally, the ability of Tα1 to activate the indoleamine 2,3-dioxygenase enzyme-which confers immune tolerance during transplantation and restrains the vicious circle of chronic inflammation-has been a turning point, suggesting a potential, specific function in immunity.
Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity.Egilmez et al., Buffalo, United States. In Immunol Invest, 2011
This article summarizes the molecular and cellular mechanisms that regulate the activity of indoleamine 2,3-dioxygenase (IDO), a potent immune-suppressive enzyme, in dendritic cells (DCs).
Highlights of 10 years of immunology in Nature Reviews Immunology.O'Garra et al., New Haven, United States. In Nat Rev Immunol, 2011
Highlights include our improved understanding of Toll-like receptor signalling, and of immune regulation mediated by regulatory T cells, indoleamine 2,3-dioxygenase, myeloid-derived suppressor cells and interleukin-10.